Investments
15Portfolio Exits
2About Asahi Kasei Ventures
Asahi Kasei is a diversified business based in Tokyo focused on three primary sectors: Materials, Homes and Healthcare. Asahi Kasei Corporate Venture Capital focuses on investing in global companies in areas of strategic importance to Asahi Kasei. The company's mission is to create new long-term business opportunities for Asahi Kasei.
Want to inform investors similar to Asahi Kasei Ventures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Asahi Kasei Ventures News
Feb 3, 2022
Koya Medical, an Oakland, Calif.-based healthcare company focused on advancing lymphatic and venous care through a comprehensive suite of people-centric platforms, closed a $26m Series B financing.The round was led by 3×5 Partners, along with new investors including Asahi Kasei Ventures, Cadence Healthcare Ventures, and existing investors Arboretum Ventures and Scientific Health Development, among others.Led by Andy Doraiswamy, Ph.D., founder, president, and CEO, Koya Medical is a healthcare company developing breakthrough treatments for lymphedema and venous diseases to increase movement, mobility, and personalized care.Dayspring is an active compression treatment that enables movement and mobility cleared by the U.S. Food and Drug Administration (FDA) to treat lymphedema and chronic venous conditions.It is a wearable and mobility-enabled active compression system that enables movement, mobility, and personalized care. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.
Asahi Kasei Ventures Investments
15 Investments
Asahi Kasei Ventures has made 15 investments. Their latest investment was in Swing Therapeutics as part of their Series A on June 6, 2022.
Asahi Kasei Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/16/2022 | Series A | Swing Therapeutics | $10.3M | Yes | 2 | |
2/3/2022 | Series B | Koya Medical | $26M | Yes | 3x5 Partners, Arboretum Ventures, Asahi Kasei Ventures, Cadence Healthcare Ventures, Scientific Health Development, and Undisclosed Investors | 10 |
6/23/2021 | Series B - II | Glycomine | $35M | Yes | 12 | |
5/27/2021 | Series C | |||||
5/6/2021 | Unattributed VC |
Date | 6/16/2022 | 2/3/2022 | 6/23/2021 | 5/27/2021 | 5/6/2021 |
|---|---|---|---|---|---|
Round | Series A | Series B | Series B - II | Series C | Unattributed VC |
Company | Swing Therapeutics | Koya Medical | Glycomine | ||
Amount | $10.3M | $26M | $35M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | 3x5 Partners, Arboretum Ventures, Asahi Kasei Ventures, Cadence Healthcare Ventures, Scientific Health Development, and Undisclosed Investors | ||||
Sources | 2 | 10 | 12 |
Asahi Kasei Ventures Portfolio Exits
2 Portfolio Exits
Asahi Kasei Ventures has 2 portfolio exits. Their latest portfolio exit was EnerBee on February 04, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/4/2022 | Acquired | 1 | |||
Date | 2/4/2022 | |
|---|---|---|
Exit | Acquired | |
Companies | ||
Valuation | ||
Acquirer | ||
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
